Healthpeak Properties (NYSE:DOC – Get Free Report) had its price target decreased by Robert W. Baird from $21.00 to $20.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the real estate investment trust’s stock. Robert W. Baird’s target price suggests a potential upside of 12.96% from the stock’s current price.
A number of other equities research analysts have also weighed in on the company. Weiss Ratings restated a “hold (c-)” rating on shares of Healthpeak Properties in a research report on Wednesday, October 8th. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a report on Monday, September 15th. Morgan Stanley dropped their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, August 22nd. Scotiabank downgraded shares of Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and cut their target price for the stock from $21.00 to $19.00 in a research report on Tuesday, July 29th. Finally, Evercore ISI set a $22.00 price target on shares of Healthpeak Properties in a research report on Monday, September 15th. Seven research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and an average target price of $20.82.
Read Our Latest Stock Report on Healthpeak Properties
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last issued its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01. The firm had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The company’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter last year, the business posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, sell-side analysts forecast that Healthpeak Properties will post 1.86 earnings per share for the current year.
Institutional Investors Weigh In On Healthpeak Properties
Institutional investors have recently modified their holdings of the company. Mather Group LLC. bought a new position in Healthpeak Properties during the third quarter worth $25,000. City Holding Co. acquired a new stake in Healthpeak Properties during the 3rd quarter worth about $26,000. TCTC Holdings LLC grew its holdings in Healthpeak Properties by 124.3% during the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 751 shares during the period. Brooklyn Investment Group raised its position in shares of Healthpeak Properties by 198.9% in the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 873 shares in the last quarter. Finally, Rexford Capital Inc. acquired a new position in shares of Healthpeak Properties in the 2nd quarter valued at about $28,000. 93.57% of the stock is owned by institutional investors.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- With Risk Tolerance, One Size Does Not Fit All
- Papa John’s $2.7 Billion Takeover Bid: A Price on Untapped Value
- How to Use the MarketBeat Excel Dividend Calculator
- Is Qualcomm Up 40% or Down 20%? 2 Contrarian Takes
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
